MYC-pathway | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,363 results for “MYC-pathway”

Trials

View all 2963 →

Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma

50 participants · First posted Apr 10, 2014

Not yet recruiting

Targeting MYC in High-Risk Medulloblastoma

35 participants · First posted Jul 10, 2026

Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma

21 participants · First posted Dec 10, 2014

Drugs

View all 464 →

MYC-053

Myc-102

DCR-M1711

Organizations

View all 35 →

Pathway Therapeutics, Inc.

United States

Erasca

United States

Eledon Pharmaceuticals

United States

News

View all 4901 →

Race Oncology Discovers Novel Mechanism for Cancer Drug Targeting Previously "Undruggable" MYC Pathway

City of Hope Researchers Uncover NAT10-MYC Pathway Driving Immunotherapy Resistance in Colorectal Cancer

Dewpoint Therapeutics Cuts 70% of Workforce, Refocuses on Lead Cancer Drug DPTx3186

Page 1 of 837